Bibliographic Details
| Title: |
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan. |
| Authors: |
Gupta A; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, 98195-7610, USA., Dai Y, Vethanayagam RR, Hebert MF, Thummel KE, Unadkat JD, Ross DD, Mao Q |
| Source: |
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2006 Sep; Vol. 58 (3), pp. 374-83. Date of Electronic Publication: 2006 Jan 11. |
| Publication Type: |
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: |
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
